Adial Pharmaceuticals reports Q2 results
Source: SeekingAlpha
2025-08-14 11:14:40 ET
More on Adial Pharmaceuticals
- Adial Pharmaceuticals announces pricing of $3.6M public offering
- Seeking Alpha’s Quant Rating on Adial Pharmaceuticals
- Historical earnings data for Adial Pharmaceuticals
- Financial information for Adial Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Adial Pharmaceuticals reports Q2 results
Adial Pharmaceuticals Inc
NASDAQ: ADIL
ADIL Trading
1.79% G/L:
$1.7915 Last:
64,324 Volume:
$1.90 Open:
ADIL Latest News
March 06, 2026 08:00:00 am
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
ADIL Stock Data
$3,344,622
1,090,503
4.47%
7
N/A
Biotechnology & Life Sciences
Healthcare
US
Glen Allen
